Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment

Introduction: Chronic HC leads to the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The treatment of chronic HC with DAAs reduces mortality from LC and HCC. The study aimed to investigate the serological markers specific to HCC (PIVKA-II and AFP) in patients with chronic H...

Descripció completa

Dades bibliogràfiques

Autors principals:	Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan
Format:	Artigo
Idioma:	Inglês
Publicat:	The Journal of Infection in Developing Countries 2024-05-01
Col·lecció:	Journal of Infection in Developing Countries
Matèries:	Chronic HCV infection hepatocellular carcinoma liver cirrhosis direct-acting antiviral agents
Accés en línia:	https://jidc.org/index.php/journal/article/view/18410
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!